Ongoing Clinical Development of ABX464: ABIVAX Launches ABX464-004 Study
Go back to Ongoing Clinical Development of ABX464: ABIVAX Launches ABX464-004 Study| (NASDAQ: ABVX) | Delayed: 118.94 -1.79 (1.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $120.73 | 52 Week High | $ | |||
| Open | $120.00 | 52 Week Low | $ | |||
| Day High | $121.25 | P/E | N/A | |||
| Day Low | $118.50 | EPS | $ | |||
| Volume | 482,010 | |||||
